These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9371003)

  • 1. Monitoring for adverse drug events.
    Kennedy DL; Goldman SA
    Am Fam Physician; 1997 Nov; 56(7):1718, 1721. PubMed ID: 9371003
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward improved adverse event/suspected adverse drug reaction reporting.
    Gross R; Strom BL
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):89-91. PubMed ID: 12642971
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

  • 4. Submitting reports of adverse drug reactions to AJHP.
    Thompson CA
    Am J Hosp Pharm; 1994 Oct; 51(19):2358. PubMed ID: 7847399
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse drug reactions, MedWatch reporting and medical student education.
    Lewis LD; Nierenberg DW
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):93-5. PubMed ID: 12642972
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MedWatch Program.
    Love L; Couig MP
    J Toxicol Clin Toxicol; 1999; 37(6):803-7. PubMed ID: 10584596
    [No Abstract]   [Full Text] [Related]  

  • 9. The Food and Drug Administration's Drug Safety Oversight Board: an evolving paradigm for clinical input on drug safety topics.
    Grandinetti CA; Osborne SF
    Clin Pharmacol Ther; 2010 Aug; 88(2):269-74. PubMed ID: 20531466
    [No Abstract]   [Full Text] [Related]  

  • 10. Most adverse drug events unreported: take these steps.
    Hosp Peer Rev; 2007 Oct; 32(10):143-5. PubMed ID: 17957885
    [No Abstract]   [Full Text] [Related]  

  • 11. When is a medical product too risky? An interview with FDA's top drug official. Interview by Tamar Nordenberg.
    Woodcock J
    FDA Consum; 1999; 33(5):8-11, 13. PubMed ID: 10522164
    [No Abstract]   [Full Text] [Related]  

  • 12. Beware of new drugs, study suggests.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 May; 13(10):1-2, 5. PubMed ID: 12492085
    [No Abstract]   [Full Text] [Related]  

  • 13. Data incompatibility of adverse event reports electronically submitted to the AERS database.
    Glass LM
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):212-3. PubMed ID: 18236510
    [No Abstract]   [Full Text] [Related]  

  • 14. A history of adverse drug experiences: Congress had ample evidence to support restrictions on the promotion of prescription drugs.
    Waxman HA
    Food Drug Law J; 2003; 58(3):299-312. PubMed ID: 14626231
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug reactions.
    O'Donnell J
    Leg Med; 1994; ():229-67. PubMed ID: 7830481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the quality of adverse drug reaction reporting by 4th-year medical students.
    Rosebraugh CJ; Tsong Y; Zhou F; Chen M; Mackey AC; Flowers C; Toyer D; Flockhart DA; Honig PK
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):97-101. PubMed ID: 12642973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug safety special: chasing shadows.
    Frantz S
    Nature; 2005 Mar; 434(7033):557-8. PubMed ID: 15800592
    [No Abstract]   [Full Text] [Related]  

  • 18. Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability--FDA. Notice.
    Fed Regist; 1993 Jun; 58(105):31596-614. PubMed ID: 10171452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced disorders.
    Holland EG; Degruy FV
    Am Fam Physician; 1997 Nov; 56(7):1781-8, 1791-2. PubMed ID: 9371009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing drug-risk information--what to do with all those new numbers.
    Avorn J; Schneeweiss S
    N Engl J Med; 2009 Aug; 361(7):647-9. PubMed ID: 19635948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.